 | • レポートコード：QYR2104Z5144 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、季節性情動障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（光線療法、医薬品、その他）、用途別市場規模（病院、診療所、家庭用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・季節性情動障害の市場動向 ・企業の競争状況、市場シェア ・季節性情動障害の種類別市場規模（光線療法、医薬品、その他） ・季節性情動障害の用途別市場規模（病院、診療所、家庭用、その他） ・季節性情動障害の北米市場規模2016-2027（アメリカ、カナダ） ・季節性情動障害のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・季節性情動障害のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・季節性情動障害の中南米市場規模2016-2027（メキシコ、ブラジル） ・季節性情動障害の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc. (US)、Allergan (Republic of Ireland)、Bayer AG (Germany)、Bristol-Myers Squibb Company (US)、F. Hoffmann-La Roche Ltd. (Switzerland)、Henry Schein(US)、Pfizer Inc. (US)） ・結論 |
Seasonal Affective Disorder (SAD) is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between the ages of 15 to 55, and the people who live far from the equator where winter daylight hours are too short. Some major symptoms of this disorder are hopelessness, increased appetite, weight gain, loss of the ability to concentrate, social withdrawal etc. There are some risk factors associated with this disorder such as major depressive disorder, Bipolar I disorder, Bipolar II disorder, and others.
The Americas hold the largest share in the global Seasonal affective disorder market. North America dominates the market in this region. Approximately 5% of the US population is suffering from seasonal depression Some other factors such as changing lifestyle plays an important role in market growth. South America market is also growing significantly, especially growth is higher in countries such as Brazil due to increasing awareness about various mental disorders.
Market Analysis and Insights: Global Seasonal Affective Disorder Market
The global Seasonal Affective Disorder market size is projected to reach US$ 627.3 million by 2026, from US$ 531 million in 2019, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Seasonal Affective Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Seasonal Affective Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Seasonal Affective Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Seasonal Affective Disorder market.
Global Seasonal Affective Disorder Scope and Market Size
Seasonal Affective Disorder market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Affective Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Light Therapy
Medications
Others
Segment by Application
Hospital
Clinic
Household
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie Inc. (US)
Allergan (Republic of Ireland)
Bayer AG (Germany)
Bristol-Myers Squibb Company (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Henry Schein(US)
Pfizer Inc. (US)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Affective Disorder Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Light Therapy
1.2.3 Medications
1.2.4 Others
1.3 Market by Application
1.3.1 Global Seasonal Affective Disorder Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Affective Disorder Market Perspective (2016-2027)
2.2 Seasonal Affective Disorder Growth Trends by Regions
2.2.1 Seasonal Affective Disorder Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Seasonal Affective Disorder Historic Market Share by Regions (2016-2021)
2.2.3 Seasonal Affective Disorder Forecasted Market Size by Regions (2022-2027)
2.3 Seasonal Affective Disorder Industry Dynamic
2.3.1 Seasonal Affective Disorder Market Trends
2.3.2 Seasonal Affective Disorder Market Drivers
2.3.3 Seasonal Affective Disorder Market Challenges
2.3.4 Seasonal Affective Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Seasonal Affective Disorder Players by Revenue
3.1.1 Global Top Seasonal Affective Disorder Players by Revenue (2016-2021)
3.1.2 Global Seasonal Affective Disorder Revenue Market Share by Players (2016-2021)
3.2 Global Seasonal Affective Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Seasonal Affective Disorder Revenue
3.4 Global Seasonal Affective Disorder Market Concentration Ratio
3.4.1 Global Seasonal Affective Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Affective Disorder Revenue in 2020
3.5 Seasonal Affective Disorder Key Players Head office and Area Served
3.6 Key Players Seasonal Affective Disorder Product Solution and Service
3.7 Date of Enter into Seasonal Affective Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Seasonal Affective Disorder Breakdown Data by Type
4.1 Global Seasonal Affective Disorder Historic Market Size by Type (2016-2021)
4.2 Global Seasonal Affective Disorder Forecasted Market Size by Type (2022-2027)
5 Seasonal Affective Disorder Breakdown Data by Application
5.1 Global Seasonal Affective Disorder Historic Market Size by Application (2016-2021)
5.2 Global Seasonal Affective Disorder Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Seasonal Affective Disorder Market Size (2016-2027)
6.2 North America Seasonal Affective Disorder Market Size by Type
6.2.1 North America Seasonal Affective Disorder Market Size by Type (2016-2021)
6.2.2 North America Seasonal Affective Disorder Market Size by Type (2022-2027)
6.2.3 North America Seasonal Affective Disorder Market Size by Type (2016-2027)
6.3 North America Seasonal Affective Disorder Market Size by Application
6.3.1 North America Seasonal Affective Disorder Market Size by Application (2016-2021)
6.3.2 North America Seasonal Affective Disorder Market Size by Application (2022-2027)
6.3.3 North America Seasonal Affective Disorder Market Size by Application (2016-2027)
6.4 North America Seasonal Affective Disorder Market Size by Country
6.4.1 North America Seasonal Affective Disorder Market Size by Country (2016-2021)
6.4.2 North America Seasonal Affective Disorder Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Seasonal Affective Disorder Market Size (2016-2027)
7.2 Europe Seasonal Affective Disorder Market Size by Type
7.2.1 Europe Seasonal Affective Disorder Market Size by Type (2016-2021)
7.2.2 Europe Seasonal Affective Disorder Market Size by Type (2022-2027)
7.2.3 Europe Seasonal Affective Disorder Market Size by Type (2016-2027)
7.3 Europe Seasonal Affective Disorder Market Size by Application
7.3.1 Europe Seasonal Affective Disorder Market Size by Application (2016-2021)
7.3.2 Europe Seasonal Affective Disorder Market Size by Application (2022-2027)
7.3.3 Europe Seasonal Affective Disorder Market Size by Application (2016-2027)
7.4 Europe Seasonal Affective Disorder Market Size by Country
7.4.1 Europe Seasonal Affective Disorder Market Size by Country (2016-2021)
7.4.2 Europe Seasonal Affective Disorder Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Affective Disorder Market Size (2016-2027)
8.2 Asia-Pacific Seasonal Affective Disorder Market Size by Type
8.2.1 Asia-Pacific Seasonal Affective Disorder Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Seasonal Affective Disorder Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Seasonal Affective Disorder Market Size by Type (2016-2027)
8.3 Asia-Pacific Seasonal Affective Disorder Market Size by Application
8.3.1 Asia-Pacific Seasonal Affective Disorder Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Seasonal Affective Disorder Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Seasonal Affective Disorder Market Size by Application (2016-2027)
8.4 Asia-Pacific Seasonal Affective Disorder Market Size by Region
8.4.1 Asia-Pacific Seasonal Affective Disorder Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Seasonal Affective Disorder Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Seasonal Affective Disorder Market Size (2016-2027)
9.2 Latin America Seasonal Affective Disorder Market Size by Type
9.2.1 Latin America Seasonal Affective Disorder Market Size by Type (2016-2021)
9.2.2 Latin America Seasonal Affective Disorder Market Size by Type (2022-2027)
9.2.3 Latin America Seasonal Affective Disorder Market Size by Type (2016-2027)
9.3 Latin America Seasonal Affective Disorder Market Size by Application
9.3.1 Latin America Seasonal Affective Disorder Market Size by Application (2016-2021)
9.3.2 Latin America Seasonal Affective Disorder Market Size by Application (2022-2027)
9.3.3 Latin America Seasonal Affective Disorder Market Size by Application (2016-2027)
9.4 Latin America Seasonal Affective Disorder Market Size by Country
9.4.1 Latin America Seasonal Affective Disorder Market Size by Country (2016-2021)
9.4.2 Latin America Seasonal Affective Disorder Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Affective Disorder Market Size (2016-2027)
10.2 Middle East & Africa Seasonal Affective Disorder Market Size by Type
10.2.1 Middle East & Africa Seasonal Affective Disorder Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Seasonal Affective Disorder Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Seasonal Affective Disorder Market Size by Type (2016-2027)
10.3 Middle East & Africa Seasonal Affective Disorder Market Size by Application
10.3.1 Middle East & Africa Seasonal Affective Disorder Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Seasonal Affective Disorder Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Seasonal Affective Disorder Market Size by Application (2016-2027)
10.4 Middle East & Africa Seasonal Affective Disorder Market Size by Country
10.4.1 Middle East & Africa Seasonal Affective Disorder Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Seasonal Affective Disorder Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie Inc. (US)
11.1.1 AbbVie Inc. (US) Company Details
11.1.2 AbbVie Inc. (US) Business Overview
11.1.3 AbbVie Inc. (US) Seasonal Affective Disorder Introduction
11.1.4 AbbVie Inc. (US) Revenue in Seasonal Affective Disorder Business (2016-2021)
11.1.5 AbbVie Inc. (US) Recent Development
11.2 Allergan (Republic of Ireland)
11.2.1 Allergan (Republic of Ireland) Company Details
11.2.2 Allergan (Republic of Ireland) Business Overview
11.2.3 Allergan (Republic of Ireland) Seasonal Affective Disorder Introduction
11.2.4 Allergan (Republic of Ireland) Revenue in Seasonal Affective Disorder Business (2016-2021)
11.2.5 Allergan (Republic of Ireland) Recent Development
11.3 Bayer AG (Germany)
11.3.1 Bayer AG (Germany) Company Details
11.3.2 Bayer AG (Germany) Business Overview
11.3.3 Bayer AG (Germany) Seasonal Affective Disorder Introduction
11.3.4 Bayer AG (Germany) Revenue in Seasonal Affective Disorder Business (2016-2021)
11.3.5 Bayer AG (Germany) Recent Development
11.4 Bristol-Myers Squibb Company (US)
11.4.1 Bristol-Myers Squibb Company (US) Company Details
11.4.2 Bristol-Myers Squibb Company (US) Business Overview
11.4.3 Bristol-Myers Squibb Company (US) Seasonal Affective Disorder Introduction
11.4.4 Bristol-Myers Squibb Company (US) Revenue in Seasonal Affective Disorder Business (2016-2021)
11.4.5 Bristol-Myers Squibb Company (US) Recent Development
11.5 F. Hoffmann-La Roche Ltd. (Switzerland)
11.5.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Details
11.5.2 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. (Switzerland) Seasonal Affective Disorder Introduction
11.5.4 F. Hoffmann-La Roche Ltd. (Switzerland) Revenue in Seasonal Affective Disorder Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
11.6 Henry Schein(US)
11.6.1 Henry Schein(US) Company Details
11.6.2 Henry Schein(US) Business Overview
11.6.3 Henry Schein(US) Seasonal Affective Disorder Introduction
11.6.4 Henry Schein(US) Revenue in Seasonal Affective Disorder Business (2016-2021)
11.6.5 Henry Schein(US) Recent Development
11.7 Pfizer Inc. (US)
11.7.1 Pfizer Inc. (US) Company Details
11.7.2 Pfizer Inc. (US) Business Overview
11.7.3 Pfizer Inc. (US) Seasonal Affective Disorder Introduction
11.7.4 Pfizer Inc. (US) Revenue in Seasonal Affective Disorder Business (2016-2021)
11.7.5 Pfizer Inc. (US) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Seasonal Affective Disorder Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Light Therapy
Table 3. Key Players of Medications
Table 4. Key Players of Others
Table 5. Global Seasonal Affective Disorder Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Seasonal Affective Disorder Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Seasonal Affective Disorder Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Seasonal Affective Disorder Market Share by Regions (2016-2021)
Table 9. Global Seasonal Affective Disorder Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Seasonal Affective Disorder Market Share by Regions (2022-2027)
Table 11. Seasonal Affective Disorder Market Trends
Table 12. Seasonal Affective Disorder Market Drivers
Table 13. Seasonal Affective Disorder Market Challenges
Table 14. Seasonal Affective Disorder Market Restraints
Table 15. Global Seasonal Affective Disorder Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Seasonal Affective Disorder Market Share by Players (2016-2021)
Table 17. Global Top Seasonal Affective Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder as of 2020)
Table 18. Ranking of Global Top Seasonal Affective Disorder Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Seasonal Affective Disorder Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Seasonal Affective Disorder Product Solution and Service
Table 22. Date of Enter into Seasonal Affective Disorder Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Seasonal Affective Disorder Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Seasonal Affective Disorder Revenue Market Share by Type (2016-2021)
Table 26. Global Seasonal Affective Disorder Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Seasonal Affective Disorder Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Seasonal Affective Disorder Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Seasonal Affective Disorder Revenue Market Share by Application (2016-2021)
Table 30. Global Seasonal Affective Disorder Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Seasonal Affective Disorder Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Seasonal Affective Disorder Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Seasonal Affective Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Seasonal Affective Disorder Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Seasonal Affective Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Seasonal Affective Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Seasonal Affective Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Seasonal Affective Disorder Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Seasonal Affective Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Seasonal Affective Disorder Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Seasonal Affective Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Seasonal Affective Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Seasonal Affective Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Seasonal Affective Disorder Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Seasonal Affective Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Seasonal Affective Disorder Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Seasonal Affective Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Seasonal Affective Disorder Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Seasonal Affective Disorder Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Seasonal Affective Disorder Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Seasonal Affective Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Seasonal Affective Disorder Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Seasonal Affective Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Seasonal Affective Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Seasonal Affective Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Seasonal Affective Disorder Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Seasonal Affective Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Seasonal Affective Disorder Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Seasonal Affective Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Seasonal Affective Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Seasonal Affective Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 62. AbbVie Inc. (US) Company Details
Table 63. AbbVie Inc. (US) Business Overview
Table 64. AbbVie Inc. (US) Seasonal Affective Disorder Product
Table 65. AbbVie Inc. (US) Revenue in Seasonal Affective Disorder Business (2016-2021) & (US$ Million)
Table 66. AbbVie Inc. (US) Recent Development
Table 67. Allergan (Republic of Ireland) Company Details
Table 68. Allergan (Republic of Ireland) Business Overview
Table 69. Allergan (Republic of Ireland) Seasonal Affective Disorder Product
Table 70. Allergan (Republic of Ireland) Revenue in Seasonal Affective Disorder Business (2016-2021) & (US$ Million)
Table 71. Allergan (Republic of Ireland) Recent Development
Table 72. Bayer AG (Germany) Company Details
Table 73. Bayer AG (Germany) Business Overview
Table 74. Bayer AG (Germany) Seasonal Affective Disorder Product
Table 75. Bayer AG (Germany) Revenue in Seasonal Affective Disorder Business (2016-2021) & (US$ Million)
Table 76. Bayer AG (Germany) Recent Development
Table 77. Bristol-Myers Squibb Company (US) Company Details
Table 78. Bristol-Myers Squibb Company (US) Business Overview
Table 79. Bristol-Myers Squibb Company (US) Seasonal Affective Disorder Product
Table 80. Bristol-Myers Squibb Company (US) Revenue in Seasonal Affective Disorder Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Company (US) Recent Development
Table 82. F. Hoffmann-La Roche Ltd. (Switzerland) Company Details
Table 83. F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
Table 84. F. Hoffmann-La Roche Ltd. (Switzerland) Seasonal Affective Disorder Product
Table 85. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue in Seasonal Affective Disorder Business (2016-2021) & (US$ Million)
Table 86. F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
Table 87. Henry Schein(US) Company Details
Table 88. Henry Schein(US) Business Overview
Table 89. Henry Schein(US) Seasonal Affective Disorder Product
Table 90. Henry Schein(US) Revenue in Seasonal Affective Disorder Business (2016-2021) & (US$ Million)
Table 91. Henry Schein(US) Recent Development
Table 92. Pfizer Inc. (US) Company Details
Table 93. Pfizer Inc. (US) Business Overview
Table 94. Pfizer Inc. (US) Seasonal Affective Disorder Product
Table 95. Pfizer Inc. (US) Revenue in Seasonal Affective Disorder Business (2016-2021) & (US$ Million)
Table 96. Pfizer Inc. (US) Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seasonal Affective Disorder Market Share by Type: 2020 VS 2027
Figure 2. Light Therapy Features
Figure 3. Medications Features
Figure 4. Others Features
Figure 5. Global Seasonal Affective Disorder Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Household Case Studies
Figure 9. Other Case Studies
Figure 10. Seasonal Affective Disorder Report Years Considered
Figure 11. Global Seasonal Affective Disorder Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Seasonal Affective Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Seasonal Affective Disorder Market Share by Regions: 2020 VS 2027
Figure 14. Global Seasonal Affective Disorder Market Share by Regions (2022-2027)
Figure 15. Global Seasonal Affective Disorder Market Share by Players in 2020
Figure 16. Global Top Seasonal Affective Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Seasonal Affective Disorder Revenue in 2020
Figure 18. Global Seasonal Affective Disorder Revenue Market Share by Type (2016-2021)
Figure 19. Global Seasonal Affective Disorder Revenue Market Share by Type (2022-2027)
Figure 20. North America Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Seasonal Affective Disorder Market Share by Type (2016-2027)
Figure 22. North America Seasonal Affective Disorder Market Share by Application (2016-2027)
Figure 23. North America Seasonal Affective Disorder Market Share by Country (2016-2027)
Figure 24. United States Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Seasonal Affective Disorder Market Share by Type (2016-2027)
Figure 28. Europe Seasonal Affective Disorder Market Share by Application (2016-2027)
Figure 29. Europe Seasonal Affective Disorder Market Share by Country (2016-2027)
Figure 30. Germany Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Seasonal Affective Disorder Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Seasonal Affective Disorder Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Seasonal Affective Disorder Market Share by Region (2016-2027)
Figure 40. China Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Seasonal Affective Disorder Market Share by Type (2016-2027)
Figure 48. Latin America Seasonal Affective Disorder Market Share by Application (2016-2027)
Figure 49. Latin America Seasonal Affective Disorder Market Share by Country (2016-2027)
Figure 50. Mexico Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Seasonal Affective Disorder Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Seasonal Affective Disorder Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Seasonal Affective Disorder Market Share by Country (2016-2027)
Figure 56. Turkey Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Seasonal Affective Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Inc. (US) Revenue Growth Rate in Seasonal Affective Disorder Business (2016-2021)
Figure 60. Allergan (Republic of Ireland) Revenue Growth Rate in Seasonal Affective Disorder Business (2016-2021)
Figure 61. Bayer AG (Germany) Revenue Growth Rate in Seasonal Affective Disorder Business (2016-2021)
Figure 62. Bristol-Myers Squibb Company (US) Revenue Growth Rate in Seasonal Affective Disorder Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue Growth Rate in Seasonal Affective Disorder Business (2016-2021)
Figure 64. Henry Schein(US) Revenue Growth Rate in Seasonal Affective Disorder Business (2016-2021)
Figure 65. Pfizer Inc. (US) Revenue Growth Rate in Seasonal Affective Disorder Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の季節性情動障害治療市場規模・現状・予測（2021年-2027年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…- 世界の季節性インフルエンザワクチン治療薬市場規模・現状・予測（2021年-2027年） Influenza vaccine typically known as flu shot and is used for protection against influenza virus. Market Analysis and Insights: Global Seasonal Influenza Vaccines Therapeutics Market The global Seasonal Influenza Vaccines Therapeutics market size is projected to reach US$ XX million by 2026, from U…
- 世界の全般性不安障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global General Anxiety Disorder Therapeutics Market The global General Anxiety Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の自閉症スペクトラム障害市場規模・現状・予測（2021年-2027年） Autism spectrum disorder (ASD) is a neurological and developmental disorder that begins early in childhood and lasts throughout a person's life. It affects how a person acts and interacts with others, communicates, and learns. It includes what used to be known as Asperger syndrome and pervasive deve…
- 世界の大うつ病性障害市場規模・現状・予測（2021年-2027年） Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …